APA (7th ed.) Citation

CA, G., M, v. d. V., J, P., E, J., L, B., T, L., . . . M, C. (2024). Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study. Journal of the International Association of Providers of AIDS Care, 23, 23259582241269837. https://doi.org/10.1177/23259582241269837

Chicago Style (17th ed.) Citation

CA, Gutner, et al. "Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study." Journal of the International Association of Providers of AIDS Care 23 (2024): 23259582241269837. https://doi.org/10.1177/23259582241269837.

MLA (9th ed.) Citation

CA, Gutner, et al. "Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study." Journal of the International Association of Providers of AIDS Care, vol. 23, 2024, p. 23259582241269837, https://doi.org/10.1177/23259582241269837.